Dr. Yao Liu 刘耀
Chief Physician, Associate Professor
Hematologic Oncology Center, Chongqing University Cancer Hospital, Chongqing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Comprehensive diagnosis and treatment of HIV-associated lymphoma, standardized therapy for hematologic malignancies, hematopoietic stem cell transplantation, and individualized management of refractory blood tumors.
Dr. Liu is Director of the Hematology and Oncology Center at Chongqing University Cancer Hospital. A postdoctoral fellow from the University of Southern California, Dr. Liu focuses on basic and clinical research in individualized lymphoma treatment and stem cell transplantation. Dr. Liu has led multiple National Natural Science Foundation projects, published over 60 papers, and received national and provincial science and technology awards.
Professional roles
- Vice Chair, Youth Committee of Hematology Branch, Chinese Medical Association
- Member, Lymphatic System Disease Group, Hematology Branch, Chinese Medical Association
- Member, Hematology Professional Committee, Chinese Geriatrics Society
- Leader, Midwest Collaboration Group for Diagnosis and Treatment of Immunodeficiency-associated Lymphoma, CSCO Anti-Lymphoma Alliance
Name order: in Chinese the family name comes first (Liu Yao). Papers usually list the name as Yao Liu or Liu Y.
Selected publications
81 papers on PubMed matched by name and affiliation; 36 as first or senior author since 2016. Most recent first- or senior-author papers:
- Bone Marrow Transplant, 2026 (senior author): A real-world, multi-center, retrospective study of autologous hematopoietic stem cell transplantation in 33 patients with HIV-associated lymphoma in China (CALL-006 Study). PubMed 42618731
- Front Nutr, 2026 (senior author): Caregiver burden and malnutrition in patients with HIV-associated lymphoma: indirect pathways via symptom distress and family closeness, and a test of resilience as a mediator. PubMed 42865439
- Sci Rep, 2026 (senior author): Development and multicenter validation of an AI-driven detection system for DLBCL cells in bone marrow smears. PubMed 42469316
- J Pain Symptom Manage, 2026 (senior author): A Flicker in the Palm: A Narrative Reflection on Guarding Life's Last Light in CAR-T Therapy. PubMed 42150684
- Blood Cancer J, 2026 (senior author): Immune escape mechanisms and therapeutic advances in virus-associated hematological malignancies. PubMed 41741411
- J Immunother Cancer, 2026 (senior author): Serotonin transporter SERT: a novel immune checkpoint for CD8(+) T cell antitumor therapy. PubMed 41734997
- Biomed Pharmacother, 2026 (senior author): FSTL1 contribute to aggressive clinical behavior in DLBCL may by activating the DIP2A/ICAM-1-mediated adhesion mechanism. PubMed 41616470
- Curr HIV Res, 2026 (first author): HIV-Associated Lymphomas: Updates from Pathogenesis to Treatment Strategies. PubMed 40916417
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion